Back to Results
First PageMeta Content



CLEMENTIA PHARMACEUTICALS MARKS FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) AWARENESS DAY MONTREAL, CANADA, April 23, Clementia Pharmaceuticals, Inc., a privately held clinical stage biotechnology company dedicat
Add to Reading List

Document Date: 2014-06-09 11:24:40


Open Document

File Size: 310,30 KB

Share Result on Facebook
UPDATE